Kodiak Sciences Reports Positive Phase 1b APEX Stu...
Category : Clinical Trial Update 16 September 2025Chicago, IL — Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial biotechnology company focuse...
Clinical Trial Update
Seaport Therapeutics Doses First Participant in Ph...
Category : Clinical Trial Update 15 September 2025PureTech Health plc announced that its founded entity, Seaport Therapeutics, has dosed the first par...
Merck announces positive results from phase 3 STRI...
Category : Clinical Trial Update 12 September 2025"Merck, known as MSD outside of the United States and Canada, announced positive results from t...
Alchemab initiates phase 1 trial of ATLX-1282 and...
Category : Clinical Trial Update 11 September 2025"Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops na...
Endo Presents Plantar Fibromatosis and Plantar Fas...
Category : Clinical Trial Update 11 September 2025"Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that two presentations re...
Latest Newsletter Post
-
Kodiak Sciences Reports Positive Ph..
16 September 2025
-
AMO Pharma Reports Long-Term Safety..
16 September 2025
-
Argo Biopharma Secures IND Approval..
16 September 2025
-
Philips and Masimo Renew Strategic..
15 September 2025
-
Seaport Therapeutics Doses First Pa..
15 September 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com